BlackRock’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-3,289
| Closed | -$2K | – | 5056 |
|
|
2019
Q2 | $2K | Sell |
3,289
-37,825
| -92% | -$23K | ﹤0.01% | 4876 |
|
|
2019
Q1 | $51K | Sell |
41,114
-2,814
| -6% | -$3.49K | ﹤0.01% | 4426 |
|
|
2018
Q4 | $37K | Sell |
43,928
-804
| -2% | -$677 | ﹤0.01% | 4469 |
|
|
2018
Q3 | $132K | Buy |
44,732
+1,809
| +4% | +$5.34K | ﹤0.01% | 4341 |
|
|
2018
Q2 | $158K | Sell |
42,923
-637,682
| -94% | -$2.35M | ﹤0.01% | 4316 |
|
|
2018
Q1 | $2.38M | Sell |
680,605
-10,259
| -1% | -$35.9K | ﹤0.01% | 3596 |
|
|
2017
Q4 | $2.16M | Buy |
690,864
+11,375
| +2% | +$35.5K | ﹤0.01% | 3623 |
|
|
2017
Q3 | $4.78M | Buy |
679,489
+13,028
| +2% | +$91.6K | ﹤0.01% | 3421 |
|
|
2017
Q2 | $6.15M | Buy |
666,461
+654,842
| +5,636% | +$6.04M | ﹤0.01% | 3360 |
|
|
2017
Q1 | $125K | Buy |
11,619
+6,117
| +111% | +$65.8K | ﹤0.01% | 4241 |
|
|
2016
Q4 | $46K | Buy |
+5,502
| New | +$46K | ﹤0.01% | 2920 |
|